Ropes & Gray Represents Chiesi Group in Collaboration With Gossamer Bio
May 09, 2024
May 09, 2024
BOSTON, Massachusetts, May 9 -- Ropes and Gray, a law firm, issued the following news on on May 8, 2024:
Ropes & Gray advised Parma, Italy-based biopharmaceutical company Chiesi Group in a global strategic collaboration with Gossamer Bio to develop and commercialize Gossamer's pulmonary arterial hypertension treatment seralutinib. The transaction was announced on May 6.
Under the agreement, Gossamer will lead the global development of seralutinib in pulmonary a . . .
Ropes & Gray advised Parma, Italy-based biopharmaceutical company Chiesi Group in a global strategic collaboration with Gossamer Bio to develop and commercialize Gossamer's pulmonary arterial hypertension treatment seralutinib. The transaction was announced on May 6.
Under the agreement, Gossamer will lead the global development of seralutinib in pulmonary a . . .